Five largecap names that investors should keep an eye on today!

Five largecap names that investors should keep an eye on today!

by 5paisa Research Team Last Updated: 2022-06-06T11:23:28+05:30

Check out these largecap companies making headlines in today’s trading session. 

These largecap companies are in the news on Monday. Let us see why! 

Aurobindo Pharma Ltd: The company has received approval from the US Food and Drugs for naproxen sodium and pseudoephedrine hydrochloride drug. Today at 11:05 am, the scrip is trading at Rs 523.35, a decline of 0.95 %.

NTPC Ltd: NTPC has signed a Memorandum of Understanding (MoU) with MECON to avail consultancy and project management services for its coal mines. The pact will further help in strengthening the infrastructure facilities at the NTPC coal mine. Today at 11:05 am, the scrip is trading at Rs 156.70, a gain of 1.06 %.

Tata Consumers Product Ltd:  Tata Starbucks, the subsidiary arm of Tata Consumer Products reported a 76% surge in its revenue to Rs 636 crore. As operations have normalised post the pandemic, losses faced by Starbucks has substantially reduced. Today at 11:05 am, the scrip is trading at Rs 750.55 a decline of 0.38 %. 

Sun Pharmaceuticals Industries Ltd: Sun Pharmaceutical Industries is planning to increase its field force in the domestic market by 10% this fiscal year to drive twin objectives of brand focus and geographical expansion. Considering the market condition, the field force expansion done in FY21 has performed well. Today at 11:05 am, the scrip is trading at Rs 865.85, a gain of 0.10 %.

Coal India Ltd:  The company has registered a decline in May compared to the year-ago month in the coal dispatch to captive power plants and sectors like cement. While the fuel supply by Coal India to captive power plants dropped 39.74% in May 2022 over the year-ago period, dispatch to the cement sector declined 16.74%. Today at 11:05 am, the scrip is trading at Rs 194.55, a decline of 1.24 %.


Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

Open Free Demat Account

& get benefits worth 2100*

 
Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number